Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jiangfang Baoxin is a traditional Chinese medicine (TCM) formulation, most commonly available as a capsule, used in combination with conventional Western medicine for the treatment of coronary heart disease (CHD), particularly after percutaneous coronary intervention (PCI). It is being studied in clinical trials for its efficacy and safety in reducing major adverse cardiac events and improving cardiac function. The precise herbal composition and mechanism of action are not fully detailed in the available sources, but it is positioned as an adjunct therapy to standard CHD treatments.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Jiangfang Baoxin.